Shirin heads Global Clinical Affairs at Agilent Technologies, with responsibility for development and execution of clinical strategies to support Agilent’s Cancer Diagnostics, Genomics Solutions, Life Sciences and Clinical environment across the enterprise.
Prior to joining Agilent, Shirin was Director of Global Clinical Affairs at Medtronic with responsibility for disease screening and therapeutic products for the Minimally Invasive Therapies Group. Shirin joined the early team at BARRX Medical in 2006 where she developed and executed the clinical strategy that contributed to BARRX’s success. BARRX was acquired by Covidien in 2012 which subsequently merged with Medtronic.
Shirin has held senior Clinical and Regulatory positions for over 2 decades. She is considered an SME in the field of Clinical Affairs. Shirin holds an MS in Chemistry from San Jose State University / Stanford University, an MS in Biochemistry from Bombay University, and a BS in Life Sciences and Biochemistry. Shirin has published several papers in peer reviewed journals and has 2 patents.